Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms.

@article{Raida2014ComparisonOR,
  title={Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms.},
  author={Luděk Raida and Zuzana Rusinakova and Edgar Faber and Romana Szotkowska and Peter Rohon and Ivana Skoumalov{\'a} and Martina Divok{\'a} and Zuzana Pikalov{\'a} and Karel Indr{\'a}k and Kateřina Langov{\'a}},
  journal={International journal of hematology},
  year={2014},
  volume={100 6},
  pages={582-91}
}
In the present study we compared outcomes of patients with myeloid neoplasms undergoing allogeneic hematopoietic stem cell transplantation after fludarabine-based regimens with melphalan (FM140) or 3-day busulfan (FB3). The FM140 and FB3 combinations were administered to 21 and 27 patients, respectively. Efforts for early reduction (from day +30 to 60) and discontinuation (until day +100 to 130) of prophylactic immunosuppression were a component of the post-transplant approach. Following FB3… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-3 of 3 extracted citations

Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2018
View 6 Excerpts
Highly Influenced

ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2009
View 1 Excerpt

Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2003
View 1 Excerpt

Similar Papers

Loading similar papers…